{
    "Rank": 940,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT02622815",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "AIRC5xmille - 12237"
                },
                "Organization": {
                    "OrgFullName": "A.O. Ospedale Papa Giovanni XXIII",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Hypercoagulation Screening in Cancer",
                "OfficialTitle": "Hypercoagulation Screening as Innovative Tool for Risk Assessment, Early Diagnosis and Prognosis in Cancer",
                "Acronym": "HYPERCAN"
            },
            "StatusModule": {
                "StatusVerifiedDate": "October 2018",
                "OverallStatus": "Unknown status",
                "LastKnownStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "April 2012",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 2019",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "January 2020",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "November 24, 2015",
                "StudyFirstSubmitQCDate": "December 4, 2015",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "December 7, 2015",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "October 26, 2018",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "October 29, 2018",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "ANNA FALANGA",
                    "ResponsiblePartyInvestigatorTitle": "Director of the Division of Immunohematology and Transfusion Medicine",
                    "ResponsiblePartyInvestigatorAffiliation": "Papa Giovanni XXIII Hospital"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "A.O. Ospedale Papa Giovanni XXIII",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Associazione Italiana per la Ricerca sul Cancro",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Istituto Neurologico Mediterraneo Neuromed S. R. L",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Fondazione Humanitas per la Ricerca",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "ASL Roma 1",
                            "CollaboratorClass": "UNKNOWN"
                        },
                        {
                            "CollaboratorName": "Istituti Ospedalieri Bergamaschi Srl",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "ASST Bergamo Ovest",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Istituti Tumori Giovanni Paolo II",
                            "CollaboratorClass": "NETWORK"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "There is a complex, mutual relationship between cancer and thrombosis. Indeed, the tumor has the capacity to activate the hemostatic system and this leads to an increased thrombotic risk in cancer patients. Even in the absence of clinical manifestations, cancer patients are commonly characterized by hemostatic abnormalities, recognized only by laboratory testing, which define the 'hypercoagulable state'. Of interest, hypercoagulation has been repeatedly reported to be associated with tumor progression and poor prognosis in various carcinomas. On the other hand, thrombotic event can represent the first signal of the presence of an occult tumor. These findings suggest that the coagulant pathway might play a role in the preclinical phase of cancer. The investigators hypothesize that a persistent, subclinical activation of the hemostatic system in an otherwise healthy subject, may predispose not only to thrombosis, but also to tumor formation and spreading. A major problem in primary cancer prevention is the lack of effective predictive markers of the disease. The HYPERCAN is an ongoing prospective Italian multicenter study organized around two tightly-interconnected research programs aiming to: 1_the assessment of thrombotic markers as a tool for cancer risk prediction in two large populations of healthy subjects, i.e. a group of healthy blood donors of Bergamo and Milano Provinces and a subgroup of Moli-sani subjects of the Molise region; and 2_ the evaluation whether thrombotic markers and/or the occurrence of overt thrombosis (or disseminated intravascular coagulation) may be prognostic of cancer disease outcomes (i.e. overall survival, progression free survival in metastatic cancer, disease free survival in limited disease) in cancer patients with different types of solid tumors (i.e. breast, lung and gastrointestinal cancers).\n\nTherefore, the assessment of cancer risk occurrence in healthy individuals might be useful for anticipation of cancer diagnosis. In addition, the results of this study might help to evaluate whether thrombotic markers may be prognostic of cancer outcomes independently of the disease extension."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Healthy Blood Donors",
                        "Moli-sani Subjects",
                        "Cancer Patients"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Hypercoagulation",
                        "Thrombosis",
                        "Cancer Risk Assessment",
                        "Cancer Prognosis"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Control"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "whole blood, plasma, serum and tissue"
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "16000",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Healthy blood donors",
                            "ArmGroupDescription": "10,000 highly controlled blood donors in the age range 30-70 years"
                        },
                        {
                            "ArmGroupLabel": "Moli-sani subjects",
                            "ArmGroupDescription": "A sample of 1,000 tumor cases have been identified so far and samples from these participants will be analyzed compared to 1,000 controls from randomly extracted from the Moli-sani cohort (parent cohort)."
                        },
                        {
                            "ArmGroupLabel": "Cancer patients",
                            "ArmGroupDescription": "4,000 Patients with breast, lung, and gastrointestinal tumors."
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Number of blood donors with a diagnosis of cancer",
                            "PrimaryOutcomeDescription": "Samples collected from identified participants with cancer diagnosis will be assessed to determine the hypercoagulation profile (ratio for laboratory analysis cancer case : healthy control from same cohort = 1:3, matched for age and gender)",
                            "PrimaryOutcomeTimeFrame": "within 5 years from the date of the enrollment"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Incidence of Thrombotic events among enrolled cancer patients",
                            "PrimaryOutcomeDescription": "Identification of cancer patients with evidence of thrombotic event derived from review of clinical records.",
                            "PrimaryOutcomeTimeFrame": "within 5 years from the date of the enrollment"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Incidence of Cancer progression among enrolled cancer patients",
                            "SecondaryOutcomeDescription": "Identification of cancer patients with evidence of cancer progression derived from review of clinical records.",
                            "SecondaryOutcomeTimeFrame": "within 5 years from the date of the enrollment"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Blood donors_\n\nInclusion Criteria:\n\ngood health\nsigned informed consent.\n\nExclusion Criteria: (considering 10-15 days from blood sampling)\n\ninflammations/infections/fever;\nrecent vaccinations;\nrecent surgery;\nanticoagulant therapy.\n\nCancer patients_\n\nInclusion Criteria:\n\nwith life expectation higher than 3 months;\npatients with breast, lung or gastrointestinal tumors candidated for chemotherapy regimen;\nECOG PS 0-2;\nadeguate bone marrow and renal function;\nsigned informed consent.\n\nExclusion Criteria:\n\nacute medical illness;\nterminal conditions or life expectancy less than 3 months;\nunder low molecular weight heparin at therapeutic dosage.",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Blood donors (age range 30-70 years), who agree to participate, fulfill a specific questionnaire on their lifestyle and donate venous blood samples at the enrollment into the study, and after 6-12 months.\n\nThe parental cohort of the Moli-sani project included 24,325 subjects (>35 years) from the Molise region. Blood samples have been collected and stored in the Moli-sani biobank available to this project.\n\nCancer patients of both genders (>18 years) with new diagnosis of non small cell lung cancer, gastrointestinal tumors, and breast cancer are enrolled at different recruiting sites. Blood samples are collected at the enrollment and at specific time points during follow-up without interfering with clinical management.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Anna Falanga, MD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "+39-035.267.8597",
                            "CentralContactEMail": "annafalanga@icthic.com"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Anna Falanga, MD",
                            "OverallOfficialAffiliation": "A.O. Papa Giovanni XXIII - Recruiting",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Istituti Ospedalieri Bergamaschi S.r.l. - Policlinico San Marco",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Osio Sotto",
                            "LocationState": "Bergamo",
                            "LocationZip": "24040",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Andrea D'Alessio, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "dr.dalessio@gmail.com"
                                    },
                                    {
                                        "LocationContactName": "Sara Cecchini, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "saracecchini@hotmail.it"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "A.S.S.T. Bergamo Ovest",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Treviglio",
                            "LocationState": "Bergamo",
                            "LocationZip": "24047",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Fausto Fausto, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "fausto_petrelli@asst-bgovest.it"
                                    },
                                    {
                                        "LocationContactName": "Mara Ghilardi, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "mara.ghily@asst-bgovest.it"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "I.R.C.C.S. Istituto Neurologico Mediterraneo NEUROMED",
                            "LocationStatus": "Active, not recruiting",
                            "LocationCity": "Pozzilli",
                            "LocationState": "Isernia",
                            "LocationZip": "86077",
                            "LocationCountry": "Italy"
                        },
                        {
                            "LocationFacility": "Fondazione Humanitas per la Ricerca",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Rozzano",
                            "LocationState": "Milan",
                            "LocationZip": "20089",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Armando Santoro, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "armando.santoro@cancercenter.humanitas.it"
                                    },
                                    {
                                        "LocationContactName": "Giovanna Masci, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "giovanna.masci@cancercenter.humanitas.it"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "Papa Giovanni XXIII Hospital - Oncology Unit",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Bergamo",
                            "LocationZip": "24127",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Roberto Labianca, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "rlabianca@asst-pg23.it"
                                    },
                                    {
                                        "LocationContactName": "Carlo Tondini, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "ctondini@asst-pg23.it"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "Papa Giovanni XXIII Hospital - S.I.M.T.",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Bergamo",
                            "LocationZip": "24127",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Anna Falanga, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "annafalanga@icthic.com"
                                    },
                                    {
                                        "LocationContactName": "Carmen J. Tartari, PhD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "aircfalanga@gmail.com"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "Fondazione IRCCS Istituto Nazionale dei Tumori",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Milan",
                            "LocationZip": "20133",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Filippo De Braud, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "filippo.debraud@istitutotumori.mi.it"
                                    },
                                    {
                                        "LocationContactName": "Luigi Celio, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "luigi.celio@istitutotumori.mi.it"
                                    }
                                ]
                            }
                        },
                        {
                            "LocationFacility": "ASL Roma 1 - ACO San Filippo Neri & San Giovanni Maria Addolorata Hospital",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Rome",
                            "LocationZip": "00135",
                            "LocationCountry": "Italy",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Giampietro Gasparini, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "gasparini.oncology@hotmail.it"
                                    },
                                    {
                                        "LocationContactName": "Roberta Sarmiento, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "roberta.sarmiento@yahoo.it"
                                    },
                                    {
                                        "LocationContactName": "Mauro Minelli, MD",
                                        "LocationContactRole": "Sub-Investigator"
                                    }
                                ]
                            }
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000019851",
                            "ConditionMeshTerm": "Thrombophilia"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000006402",
                            "ConditionAncestorTerm": "Hematologic Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M16376",
                            "ConditionBrowseLeafName": "Thrombosis",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M21427",
                            "ConditionBrowseLeafName": "Thrombophilia",
                            "ConditionBrowseLeafAsFound": "Hypercoagulation",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M9180",
                            "ConditionBrowseLeafName": "Hematologic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC14",
                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC15",
                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                        }
                    ]
                }
            }
        }
    }
}